Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

PRICED: Neopharmed Gentili EUR890m 7NC1 Sr Sec FRN, E+325 at par

HYC European Market: Deal Flow - General

***Corrected IPT PXD

Issuer

Term

Call

Coupon

Maturity

Size

Ranking

Type

Price

Spread

IPT-PXD

Neopharmed Gentili

7NC1

1y

E+325

29-Jun-33

€890m (up from EUR425m)

Sr Sec

Floating

100

E+325

-50


Reoffer: E+325 / 100

Launched: €890m @ E+325 at par (EUR465m upsize to refinance EUR450m 7.125% sr sec notes due 08-APR-2030 notes)

Price Talk: E+325-350, 0%, par
IPTs: High 3s, par


  • Issuer: Neopharmed Gentili S.p.A.
  • Ticker: NEGENT
  • Corporate Ratings: B3/B/B (Moody's/S&P/Fitch)
  • Issue Ratings: B3/B/B (Moody's/S&P/Fitch)
  • Instrument: Senior Secured Floating Rate Notes
  • Size: €890m (up from EUR425m)
  • Trade Date: 18-Jun-26
  • Settlement: 29-Jun-26 (T+7)
  • Maturity: 29-Jun-33
  • Margin: E+325bps
  • Floor: 0%
  • Issue Price: 100
  • Make-Whole: BUNDS + 50bps
  • Optional Redemption: Commencing 29-Jun-27 – 100%
  • Change of Control: 101
  • Interest Payment Dates: Quarterly on 15-Jan, 15-Apr, 15-Jul, 15-Oct
  • First Interest Payment Date: 15-Oct-26
  • Day Count: ACT / 365
  • Format: 144A/Reg S
  • Denominations: €100k x €1k
  • Listing: Luxembourg Stock Exchange
  • Governing Law: New York
  • ISIN:
    • Reg S: XS3416905365
    • 144A: XS3416905878
  • Sole Global Coordinator and Physical Bookrunner: BNP Paribas (B&D)
  • Joint Bookrunners: Banca Akros, CACIB, GS, IMI, JPM, Natixis
  • UOP: refinance its EUR400m sr sec FRNs due 08-Apr-30 (callable at 100), and fund a EUR23m distribution to its parent to repay a portion of the EUR157m PIK Notes (EUR465m upsize to refinance EUR450m 7.125% sr sec notes due 08-APR-2030 notes)
  • Equity Sponsors: Renaissance Partners (42.1%)/Ardian (42.1%)/Del Bono family (14.4%)
  • Timing:
    • TOE: 11:47 UKT, 18-Jun-26
    • FTT: 16:15 UKT, 18-Jun-26
  • Advertisement: This communication is an advertisement and does not constitute a prospectus for the purposes of Regulation (EU) 2017/1129 and underlying legislation. The Offering Memorandum, when published, will be available on the website of the Luxembourg Stock Exchange at: https://www.luxse.com
  • Target Market: No EU PRIIPs key information document (KID) and no UK disclosure document required by DISC have been prepared as the notes are not available to retail in EEA or UK
  • Marketing:
  • Investor Call: GIC 8:30 UKT / 9:30 CET, 16-June-2026
  • Q&A Sessions: 16/17-June-2026

https://dealroadshow.com/e/NEO2026 (Access Code: NEO2026)

https://evercall.co/oacc/46099 (GIC Registration)

We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.